banner
FGFR inhibitor Futibatinib, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ091

FGFR inhibitor Futibatinib, Purity ≥98%

Synonym: 1448169-71-8; FGFR inhibitor; TAS-120; TAS120; TAS 120

  • CAS Number: 1448169-71-8
  • Compound CID: 71621331
img
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Futibatinib, soluble in DMSO and insoluble in ethanol and water, is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against FGFR. It targets FGFR1, FGFR2, FGFR2 E566G, FGFR2 N550H, FGFR2 V5651, FGFR3, FGFR4, and wild-type FGFR2.
Molecular Weight
418.45
Molecular Formula
C22H22N6O3
Targets
FGFR1: 3.9 nM; FGFR2: 1.3 nM; FGFR2 E566G: 2.4 nM; FGFR2 N550H: 3.6 nM; FGFR2 V5651: 1-3 nM; FGFR3: 1.6 nM; FGFR4: 8.3 nM; wild-type FGFR2: 0.3 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 75 mg/mL (179.23 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Futibatinib is employed in exploring FGFR as a selective inhibitor, aiding in the development of FGFR-targeted cancer therapies.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0